Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
09/2008
09/03/2008CN100415292C New class of bioactive glycoprotein
09/03/2008CN100415291C Medicine and food dual purpose Chinese mediicnal product for proventing and treating fright wind convulsion and its manufacturing method
09/03/2008CN100415285C Zijing liver tonifying pill
09/03/2008CN100415274C Zijing pill for reinforcing kidney and soothing liver
09/03/2008CN100415272C Medicated liquid for male to health-preserving and prolonging life
09/03/2008CN100415271C Use of composition in preparing medicine and food dual purpose Chinese medicinal nutritive product for preventing and treating pavor
09/03/2008CN100415269C Cow-bezoar snake bile Sichuan fritillary bulb dispersive tablet and its preparation method
09/03/2008CN100415264C Medicated liquid for female health preserving and prolonging life
09/03/2008CN100415263C Chinese medicine for gynecological inflammation
09/03/2008CN100415262C Medicine for treating cerebral infraction and its preparing method
09/03/2008CN100415261C Ziqing tranquilizing drug
09/03/2008CN100415259C Medicine for treating coronary heart disease and preparation thereof
09/03/2008CN100415258C Chinese traditional medicine composition for treating leucopenia and preparation and quality controlling method thereof
09/03/2008CN100415254C Anti-inflammatory and heat-relieving Chinese-herb preparation
09/03/2008CN100415252C Chinese medicinal composition for strengthening body and enriching blood and its preparation method
09/03/2008CN100415251C Chinese medicine for treating tonsillitis and pharyngitis, and its preparation method
09/03/2008CN100415248C Masa Medicata Fermentate health-care preparation, and its preparation method
09/03/2008CN100415222C Methods of using and compositions comprising dopamine reuptake inhibitors
09/03/2008CN100415219C Substituted bicyclo[3.3.1]nonan-2,4,9-triones as pharmaceutical active ingredients
09/03/2008CN100415093C Autologous or homologous coagulant produced from anticoagulated whole blood
09/02/2008US7420100 Animal model lacking histone deacetylase (HDAC) for use as diagnostic tool in detection, diagnosis and prevention of cardiac hypertrophy
09/02/2008US7420045 IAPs associated cell cycle proteins, compositions and methods of use
09/02/2008US7419952 Use of exendins and agonists thereof to treat diabetes
09/02/2008US7419950 Methods of inhibiting ectopic calcification
09/02/2008US7419949 Coagulation; prevent bleeding
09/02/2008US7419948 Recombinant human Factor IX produced by a transgenic pig having an exogenous DNA stably integrated into its genome that secretes the biologically active Factor into its milk; the factor may be gamma -carboxylated
09/02/2008US7419825 Propagation of neural stem cells; obtain cells, detect expression of neuronal cell markers, recover cells expressing neuronal marker, propagate cells
09/02/2008US7419804 CASH (Caspase Homologue) with death effector domain, modulators of the function of FAS
09/02/2008US7419689 Protecting the liver from alcohol and chemically induced damage; wasabi root fiber powder, artichoke leaf extract, asparagus dehydrate, kudzu root extract, oregano extract, schisandra berry extract, notoginseng (ethanol extract of Panax notoginseng root)
09/02/2008US7419661 For use in surgical dressings where wound closure and minimal scarring is desirable
09/02/2008US7419657 Reducing antibody-mediated lipid peroxidation activity in vascular systems; idiotypic antibodies; chlamydia pneumoniae vaccines
09/02/2008CA2307807C Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture
09/02/2008CA2306350C Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics
08/2008
08/28/2008WO2008103762A1 Targeting of herpes simplex virus to specific receptors
08/28/2008WO2008103336A1 Methods for intravascular engraftment in heart
08/28/2008WO2008103301A2 Treatment of the eye using macrophages and/or agents able to affect blood vessel morphology
08/28/2008WO2008103023A1 Selected colostrum for treatment of intestinal barrier function disorders
08/28/2008WO2008102460A1 Transplantation of bone marrow stromal cell-induced neural stem cells for promoting fuctional recovery after spinal cord injury
08/28/2008WO2008101936A1 Cells for heart treatment
08/28/2008WO2008101450A1 Probiotic, gram-positive bacteria for the prophylaxis, suppression, or elimination of allergic reactions in humans
08/28/2008WO2008101428A1 Culture medium for lactobacillus acidophilus and streptococcus faecalis, composition comprising the same and preparation method thereof
08/28/2008WO2008101349A1 Recombinant viral vectors for prevention and protection against alphavirus infection
08/28/2008WO2008101344A1 Soluble bioactive lipophilic compounds compositions
08/28/2008WO2008101272A1 Method for obtaining treg-cells
08/28/2008WO2008057505A3 Suppressive macrophages, c-reactive protein and the treatment of systemic lupus erythematosus and immune thrombocytopenic purpura
08/28/2008US20080207715 Novel Inhibitors of Glutaminyl Cyclase
08/28/2008US20080207548 Immunogenic polynucleotides, expression vectors, antigen presenting host cells, diagnostic kits; cancer vaccines
08/28/2008US20080207547 Compositions and methods for the therapy and diagnosis of breast cancer
08/28/2008US20080207511 Isolated polypeptide comprising amino acid sequence encoded by polynucleotide; physiologically acceptable carriers and immunostimulants
08/28/2008US20080207486 Compositions and methods for the therapy and diagnosis of breast cancer
08/28/2008US20080206837 Stable adenoviral vectors and methods for propagation thereof
08/28/2008US20080206835 Methods and Compositions Relating to Gene Silencing
08/28/2008US20080206380 Preventing Agent Against Drug-Resistant Bacterial Infection
08/28/2008US20080206379 Production and Use of an Antioxidant Extract from Crypthecodinium Sp.
08/28/2008US20080206378 Anthelmintic Composition
08/28/2008US20080206354 Minimal skin irriation
08/28/2008US20080206353 Formulations And Treatments For Trichology
08/28/2008US20080206352 Extract for Preventing or Treating Thrombotic Diseases
08/28/2008US20080206343 Contacting with sodium butyrate; for treatment of trauma, inflammation, and degenerative disorders of the liver; model mouse
08/28/2008US20080206302 cohesive, structure-forming matrix including gel, with open porosity and serum for regenerating cartilage, bone tissue; drug delivery device and method
08/28/2008US20080206288 Tumor cells from immune privileged sites as base cells for cell-based cancer vaccines
08/28/2008US20080206280 nontarget antigen to sensitize a patient's CD8+ T cells followed with administration of a vaccine comprising a target antigen (such as a tumor-associated antigen or a pathogen-associated antigen); cancer and autoimmune diseases
08/28/2008US20080206268 HA-1 epitopes and uses thereof
08/28/2008US20080206267 Inactivation Of Genes Of The Mep Pathway
08/28/2008US20080206266 Carbohydrate ligand that specifically binds to a leczyme; nucleic acid sequence encoding a nonclassical MHC class I heavy chain; ability to associate with a beta 2 microglobulin; major histocompatibility complex transplantation molecules
08/28/2008US20080206262 complexing of multiple antigens or proteins in a controlled, multivariable fashion, to one single primary recombinant monoclonal antibody; activate dendritic cells and other cells; bound to one half of a Coherin/Dockerin pair
08/28/2008US20080206255 Antibody cancer immunotherapy
08/28/2008US20080206250 Compositions and methods for the therapy and diagnosis of breast cancer
08/28/2008US20080206249 comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides
08/28/2008US20080206245 Compositions and methods for the therapy and diagnosis of breast cancer
08/28/2008US20080206244 Compositions and methods for the therapy and diagnosis of breast cancer
08/28/2008US20080206234 Compositions and methods for the therapy and diagnosis of breast cancer
08/28/2008US20080206233 Heavy Chain And Single Domain Antibodies
08/28/2008US20080206224 Muscle contraction treatment utilizing botulinum toxin
08/28/2008US20080206223 Treatment of pompe's disease
08/28/2008US20080206218 T-helper cell peptide epitopes for use in targeting and treatment of cell prolferative disorders; immunotherapy
08/28/2008US20080206217 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules
08/28/2008US20080206216 T-helper cell peptide epitopes for use in targeting and treatment of cell prolferative disorders; immunotherapy
08/28/2008US20080206215 Promoting yeast propagation, conditioning and efficiency in fluid stream via enhancing carbohydrate and cellulose concentration of fermentation broth
08/28/2008US20080206214 Inhibition of pathogens by probiotic bacteria
08/28/2008US20080206213 Method for reducing or preventing systemic inflammation
08/28/2008US20080206212 Method for the utilization of and product containing inactivated probiotic
08/28/2008US20080206211 Composition containing a cell culture medium
08/28/2008US20080206210 gene therapy by intrathymic administration; lentiviral vectors
08/28/2008US20080206209 Myelinating or remyelinating dysmyelinated or demyelinated axons comprising: administering oligondendrocyte progenitor cells to dysmyelinated or demyelinated axons via intraventricular, intracallosal or intraparenchymal administration to brain, brain stem or spinal cord
08/28/2008US20080206208 Adipose tissue culture use in treatment and prevention of cardiomyopathies; tissue engineering; regenerative medicine
08/28/2008US20080206207 Intracoronary Device And Method Of Use Thereof
08/28/2008US20080206206 Bone marrow-derived neuronal cells
08/28/2008US20080206205 Using immunoaffinity, ficoll centrifugation and fluorescent cell sorting to isolate cells express ing cd34 antigen; treating cell proliferative disorders
08/28/2008US20080206203 Administering leukotriene antagonist such as pranlukast
08/28/2008US20080206201 Oncolytic myxovirus for targeting and destroying cancer cell; antitumor agents; tissue targeted therapy
08/28/2008US20080206200 Selected endothelial progenitor cells and methods for use
08/28/2008US20080206199 Viral vector for target destruction of cancer cells
08/28/2008US20080206197 Metabolically activated recombinant viral vectors and methods for their preparation and use
08/28/2008US20080206195 Compositions and Methods for Treating Disorders Associated with Abnormal Phosphate Metabolism
08/28/2008US20080206171 Conditioned medium and uses thereof
08/28/2008DE102007009125A1 Mittel zur Körper- oder Schönheitspflege Preparations for body and beauty care
08/28/2008CA2678875A1 Prevention and treatment for osteonecrosis and osteoradionecrosis of the jaw
08/28/2008CA2678409A1 Inoculation of recombinant viral vectors for rapid pre-exposure prevention and post-exposure protection against alphavirus-induced encephalitides
08/27/2008EP1961823A1 Fermentation and culture method, fermented plant extract, composition containing fermented plant extract, method for producing lipopolysaccharide and lipopolysaccharide